Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey

PurposeTo compare the EQ-5D, SF-6D, and SF-12 in terms of their capacity to discriminate between groups defined by relevant socio-demographic and health characteristics in a general population survey.MethodsData were obtained from the 2006 Catalan Health Interview Survey, a representative sample (n = 4,319) of the general population of Catalonia (Spain). Effect sizes (ES) and Receiver Operating Characteristic (ROC) curves were calculated to evaluate the instruments’ capacity to distinguish between groups based on socio-demographic variables, recent health problems, perceived health, psychological distress, and selected chronic conditions.ResultsAll instruments showed a similar discriminative capacity between groups based on socio-demographic variables, recent medical visit (ES = 0.47–0.55), activity limitations (ES = 0.92–0.98), perceived health (ES = 0.97–1.33), and psychological well-being (ES = 1.17–1.57). Effect sizes between respondents with and without any of fourteen selected chronic conditions were large (0.76–1.04) for 4, moderate (0.55–0.74) for 8, and small (0.17–0.39) for two on the EQ-5D index. A similar pattern was observed for the SF-12 but ES were predominantly moderate (7 conditions) or small (6 conditions) on the SF-6D.ConclusionsThe EQ-5D and SF-12 were largely comparable in estimating the health burden of chronic conditions, recent health problems, and social inequalities. The SF-6D was less sensitive than the EQ-5D index and SF-12, particularly for physical chronic conditions.

[1]  Silke Schmidt,et al.  Development of the WHOQOL-Old Module , 2005, Quality of Life Research.

[2]  A. van Straten,et al.  Comparison of EQ-5D and SF-6D utilities in mental health patients. , 2006, Health economics.

[3]  J. Brazier,et al.  The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.

[4]  J. Antó,et al.  Spanish version of the Nottingham Health Profile: translation and preliminary validity. , 1990, American journal of public health.

[5]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[6]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[7]  Jacek A Kopec,et al.  A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. , 2005, Social science & medicine.

[8]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[9]  Gaietà Permanyer-Miralda,et al.  El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos , 2005 .

[10]  Kathleenl N. Lohr,et al.  Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.

[11]  B. Starfield State of the art in research on equity in health. , 2006, Journal of health politics, policy and law.

[12]  Tommi Härkänen,et al.  The Impact of 29 Chronic Conditions on Health-related Quality of Life: A General Population Survey in Finland Using 15D and EQ-5D , 2006, Quality of Life Research.

[13]  Nancy Devlin,et al.  Variations in self-reported health status: results from a New Zealand survey. , 2000, The New Zealand medical journal.

[14]  C. Borrell,et al.  Social class inequalities in the use of and access to health services in Catalonia, Spain: what is the influence of supplemental private health insurance? , 2001, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  Alan D. Lopez,et al.  Healthy life expectancy in 191 countries, 1999 , 2001, The Lancet.

[16]  M. Johannesson,et al.  Deteriorating health status in Stockholm 1998–2002: results from repeated population surveys using the EQ-5D , 2007, Quality of Life Research.

[17]  M. Liang,et al.  Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. , 1995, Journal of clinical epidemiology.

[18]  Nick Kontodimopoulos,et al.  Validity of SF-12 summary scores in a Greek general population , 2007, Health and quality of life outcomes.

[19]  J. Seidell,et al.  Quality of life in relation to overweight and body fat distribution. , 1998, American journal of public health.

[20]  Joan Benach,et al.  Social inequalities in the impact of flexible employment on different domains of psychosocial health , 2005, Journal of Epidemiology and Community Health.

[21]  N. Bansback,et al.  The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis , 2009, Quality of Life Research.

[22]  S. Petrou,et al.  An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. , 2005, Health economics.

[23]  W. Maksymowych,et al.  The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab. , 2003, The Journal of rheumatology.

[24]  Y. Brandberg,et al.  Health-related Quality of Life Measured by the EORTC QLQ-C30: Reference Values From a Large Sample of the Swedish Population , 2000 .

[25]  D. Feeny,et al.  Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index , 2005, Medical care.

[26]  A. Domingo-Salvany,et al.  [Proposal for a social class measure. Working Group of the Spanish Society of Epidemiology and the Spanish Society of Family and Community Medicine]. , 2000, Atencion primaria.

[27]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[28]  P. Kind,et al.  A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  Jeffrey A. Johnson,et al.  Comparison of the EQ-5D and SF-12 in an adult US sample , 1998, Quality of Life Research.

[30]  A. Ferketich,et al.  Gender Differences in Quality of Life Among Cardiac Patients , 2004, Psychosomatic medicine.

[31]  C. McHorney,et al.  Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.

[32]  A. Pickard,et al.  Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. , 2000, Medical care.

[33]  Murtuza Bharmal,et al.  Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  H. V. van Stel,et al.  Health and Quality of Life Outcomes , 2006 .

[35]  X. Badia,et al.  Using the EuroQol 5-D in the Catalan General Population: Feasibility and Construct Validity , 1998, Quality of Life Research.

[36]  John E. Brazier,et al.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.

[37]  John Bankart,et al.  Comparing utility scores before and after hearing-aid provision , 2004, Applied health economics and health policy.

[38]  K. Stavem,et al.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS , 2005, Quality of Life Research.

[39]  Paul Kind,et al.  Variations in population health status: results from a United Kingdom national questionnaire survey , 1998, BMJ.

[40]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[41]  N. Bansback,et al.  Impact of the recall period on measuring health utilities for acute events. , 2008, Health economics.

[42]  Ingram Olkin,et al.  Estimation of a Single Effect Size: Parametric and Nonparametric Methods , 1985 .

[43]  M. Rué,et al.  Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain) , 2008, BMC Cancer.

[44]  Carol Jagger,et al.  Healthy Life Expectancy , 2011 .

[45]  Dongjin Kim,et al.  [Health inequality measurement in Korea using EuroQol-5 Dimension valuation weights]. , 2008, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[46]  K. Scott,et al.  Fish consumption and self-reported physical and mental health status , 2002, Public Health Nutrition.

[47]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[48]  M. Suarez‐Almazor,et al.  Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.

[49]  J. Kruse,et al.  The SF-36 summary scores and their relation to mental disorders: physical functioning may affect performance of the summary scores. , 2007, Journal of clinical epidemiology.

[50]  D. Spiegelhalter,et al.  Quality of life measures in health care. I: Applications and issues in assessment. , 1992, BMJ.

[51]  J. Fisk,et al.  A comparison of health utility measures for the evaluation of multiple sclerosis treatments , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  Barbara Gandek,et al.  How to score version 2 of the SF-12(R) health survey (with a supplement documenting version 1) , 2005 .

[53]  Paul D. Williams,et al.  A user's guide to the General Health Questionnaire , 1988 .

[54]  Paul Kind,et al.  Measuring Population Health: A Comparison Of Three Generic Health Status Measures , 2003, Medical care.

[55]  M. Herdman,et al.  Sociodemographic and health-related correlates of psychiatric distress in a general population , 2003, Social Psychiatry and Psychiatric Epidemiology.

[56]  Graeme Hawthorne,et al.  Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36. , 2003, Journal of clinical epidemiology.

[57]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.